Candesartan 相關新聞

← 返回新聞總覽

---

Candesartan 目前有 0 則相關新聞報導，預測適應症 9 個。

本頁整合 Candesartan 的 AI 預測適應症與最新健康新聞，橘色標示的適應症表示近期有相關新聞報導。

藥物資訊

• 證據等級：L5
• 預測適應症（9 個）：
  • Migraine with brainstem aura | 99.96% | L3 | Research Question — related migraine subtype; no dedicated trials; mechanistic rationale via brainstem AT1R expression（99.0%）
  • Migraine with or without aura, susceptibility to | 99.94% | L2 | Research Question — precision medicine angle; RAAS polymorphisms (ACE I/D) may predict ARB response（99.0%）
  • Pulmonary hypertension | 99.93% | L4 | Hold — theoretical RAAS–pulmonary vascular link, but PAH is primarily driven by ET-1/NO/prostacyclin pathways; clinical trials retrieved were irrelevant（99.0%）
  • Prinzmetal angina | 99.91% | L5 | Hold — theoretical AT1R–coronary spasm link, but calcium-channel–mediated mechanism dominates; no supporting data（99.0%）
  • Kyphoscoliotic heart disease | 99.90% | L5 | Hold — mechanical aetiology predominates; ARB intervention not feasible（99.0%）
  • Atrophoderma vermiculata | 99.87% | L5 | Hold — no biological rationale linking RAAS to this rare follicular skin disorder（99.0%）
  • Ulerythema ophryogenesis | 99.86% | L5 | Hold — highly speculative AT1R–MAPK pathway hypothesis; no supporting data（99.0%）
  • Benign prostatic hyperplasia | 99.84% | L5 | Hold — local prostatic RAAS is plausible but unvalidated clinically; would require Phase 1 exploration（99.0%）
  • Alopecia | 99.78% | L5 | Hold — purely theoretical follicular vasculature hypothesis; no preclinical or clinical evidence（99.0%）

查看完整藥物報告 →

相關新聞（0 則）

目前沒有相關新聞報導。當有新聞提到此藥物時，系統會自動收集並顯示在這裡。

免責聲明：本頁新聞由系統自動收集，僅供研究參考，不構成醫療建議。